Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Continuous Thoracic Paravertebral Block for Open Hepatectomy
NCT03990922Completed
- Start
- Jun 2019
- Primary completion
- Nov 2019
- Modality
- Targeted Liposomes, Stealth (PEGylated) Liposomes, Conventional Liposomes
- Countries
- 1
01
Overview
Randomised, double-blind trial of ropivacaine hydrochloride liposomal suspension injection in postoperative pain. Primary endpoint: Quality of Recovery at 7 days. Started Jun 2019; status: completed.
02
Drugs
ropivacaine hydrochloride liposomal suspension injection
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT03990922.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03990922.